Top Machine Learning Companies in Bengaluru (90)

Strong Revenue Growth: Q2 2026 total net revenue rose 4% sequentially to $15.9 billion. Integration of Discover and Brex contributed to higher non‑interest income and broader payments capabilities.

Profitability: Q2 2026 net income reached $3.0 billion, up from $2.2 billion in Q1 2026, alongside a net interest margin of 8.01%. Management also cited strong credit performance, including a $662 million reserve release.

Market Expansion: Acquisition‑driven scale is broadening reach, with the Discover deal (closed May 18, 2025) and Brex (closed April 7, 2026) adding network and corporate card/spend‑management capabilities. Balance‑sheet growth continued in Q2 2026 as period‑end loans rose 2% to $457.2 billion and total assets reached $673.8 billion.

Strong Market Position & Advantage: After closing the SP+ take‑private in May 2024, the company states it became the largest parking network/operator in North America with 4,000+ locations, later citing 4,200+ locations and about $5B in annual payments. This scale provides reach to 50M+ consumers and a platform for broad deployment of its AI-driven model.

Investor Backing & Capital Strength: In November 2025, the company announced $1.6B in new capitalization (a $1.1B Term Loan B plus a $500M Series D) to accelerate expansion beyond parking. Earlier financing linked to the SP+ acquisition further underscores substantial access to capital.

Market Expansion: The platform is extending into adjacent sectors—retail, hospitality, fueling, mobility, and aviation—with moves such as the Joby Aviation partnership to develop 25 vertiport sites. Acquisitions like Oosto broaden capabilities supporting expansion beyond core parking.

Strong Market Position & Advantage: Repeated Leader placements in Gartner’s DEX Magic Quadrant (2024–2026) and Forrester’s 2024 EUEM Wave indicate durable competitive standing and sustained category momentum. These recognitions coincide with communications citing 1,200–1,500+ customers and 20M+ endpoints, underscoring broad enterprise adoption.

Product Line Growth: New offerings such as Adopt on Infinity (2025) and the Spark personal IT agent (2026), plus integrations like GoTo/Rescue and a government-focused AWS Marketplace listing, expand use cases and routes to market. The 2024 acquisition of AppLearn further broadened capabilities into digital adoption.

Investor Backing & Capital Strength: A late‑2025 majority investment by Vista Equity Partners at an approximately $3B valuation signals strong external confidence and provides resources for scaling. This step-up from the 2021 round supports continued product and go‑to‑market execution.

Strong Revenue Growth: Company communications describe ARR more than tripling in 2025, marking its strongest year to date. These disclosures point to clear top‑line momentum into 2026.

Product Line Growth: Announcements highlight expanded AI functionality for healthcare in June 2026 alongside ongoing platform updates. This indicates continued investment in new capabilities and vertical depth.

Strong Hiring & Retention: Multiple senior appointments in mid‑2026, including an EVP of Technology & Operations and additional leadership roles, suggest active scaling of the executive and technical bench. References to broader team expansion reinforce organizational build‑out.

Strong Revenue Growth: Record fiscal Q3 2026 revenue of $41.46B with GAAP net income of $28.24B and guidance to roughly $50B for Q4 signal sharp top-line acceleration. Momentum spans data center, client/mobile, and automotive/embedded, reflecting broad-based demand.

Innovation-Driven Growth: Emphasis on high-bandwidth memory and advanced DRAM/NAND for AI data centers, including 1‑gamma DDR5 RDIMMs and an HBM4/HBM4E roadmap, anchors growth in the fastest-ramping segments. Company materials and Computex updates highlight next‑gen shipments and timelines aligned to AI infrastructure build‑outs.

Strategic Partnerships: Long‑term strategic customer agreements with automotive players (e.g., Qualcomm, HARMAN, Hyundai Mobis, Ford) and collaborations with Intel and AMD enhance demand visibility and ecosystem reach. New U.S. commitments of up to $3B to strengthen the semiconductor ecosystem underscore expanding supply‑chain partnerships.

Strong Revenue Growth: Total revenue increased to $255.9M in 2025 with software up and drug‑discovery more than doubling, while operating expenses declined year over year. Early 2026 also showed momentum, with first‑half revenue modestly higher and Q2 posting year‑over‑year growth.

Strategic Partnerships: New and expanded agreements—such as Bristol Myers Squibb deploying Bunsen and a July 2026 discovery collaboration with Simcere—broaden platform use and collaboration optionality. The Lilly/Ajax transaction also validated the model and supported a higher 2026 drug‑discovery outlook.

Product Line Growth: The introduction of Bunsen, an agentic AI co‑scientist, expands the software portfolio and is being deployed at scale within BMS. This product push complements growth in ACV and broader platform adoption.

Strong Revenue Growth: Company communications describe substantially accelerated revenue growth in 2024 with “exceptional momentum” continuing into Q1 2025 and performance on track to exceed financial targets. These statements align with concurrent product launches and go-to-market investments.

Product Line Growth: Multiple new offerings and upgrades—such as Accuris Thread (2025), an AI Assistant (2026), AI-powered BOM Intelligence (2026), and Engineering Workbench enhancements—signal sustained investment in the roadmap. This cadence broadens solution scope and supports upsell and cross-sell potential.

Market Expansion: A new global headquarters in Denver and additional offices in the UK, India, Malaysia, and Japan indicate an expanding geographic footprint. Senior commercial hires (e.g., a CRO in 2025 and a Head of Sales, Americas in 2026) further suggest scaling sales capacity.

Strong Market Position & Advantage: Industry assessments consistently position Ericsson as a top‑tier leader in 5G RAN and core, particularly outside China. Recognition by major analyst firms and marquee Tier‑1 wins point to durable competitive standing.

Cost & Operational Efficiency: Adjusted gross margins near the high‑40s and expanding Cloud Software & Services margins indicate effective cost discipline and mix improvements. Management has executed restructuring to lower the cost base amid rising component costs.

Investor Backing & Capital Strength: A strong net cash position and sizable shareholder returns (dividends/buybacks) were emphasized in Q2 2026. This financial flexibility supports navigation of a flat capex cycle and investment in IPR and enterprise initiatives.

Strong Revenue Growth: Consolidated revenues increased from $253 billion in 2024 to $270.6 billion in 2025, with quarterly gains such as Q4 2025 up 8% year over year. Growth was led primarily by Optum Rx and supported by steady contributions from Optum Insight.

Market Expansion: Expansion through acquisitions such as Holston Medical Group (August 2025) and Alegeus (July 2026), alongside earlier combinations like Change Healthcare and Atrius Health, broadened capabilities across care, pharmacy, and payments. These moves extend Optum’s platform into adjacent services and operating domains.

Diversified Revenue Streams: A multi-segment model—Rx, Insight, and Health—helps sustain aggregate growth even as individual lines vary, with pharmacy and technology businesses offsetting care-delivery softness. Parent-company commentary continuing to frame Optum as a growth engine and raising 2026 guidance underscores the benefit of this portfolio effect.